Global Gut Microbiome Market 2020 by Company, Type and Application, Forecast to 2025

  • receipt Report ID : 87611
  • calendar_today Published On: Aug, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The Gut Microbiome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Gut Microbiome sales will be xx in 2020 from Gut Microbiome million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Gut Microbiome market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Gut Microbiome industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Gut Microbiome and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation

Gut Microbiome market is split by Disease and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Disease and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Disease, Gut Microbiome market has been segmented into Obesity, Inflammatory Bowel Disease (IBD), Diabetes, Others, etc.

Breakdown by Application, Gut Microbiome has been segmented into Human, Animal, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Gut Microbiome market presented in the report. This section sheds light on the sales growth of different regional and country-level Gut Microbiome markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gut Microbiome market.

For Japan, this report analyses the Japan market by players, Disease and Application, for the period 2015-2025.

Competitive Landscape and Gut Microbiome Market Share Analysis

Gut Microbiome competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Gut Microbiome revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gut Microbiome revenue and market share for each player covered in this report.

The major players covered in Gut Microbiome are: Viome, LNC Therapeutics, Novome Biotechnologies, Carbiotix, Caelus Health, Ixcela, Inc, Assembly Biosciences, ProDigest, Kintai Therapeutics, AnimalBiome, Enterome BioScience, etc. Among other players domestic and global, Gut Microbiome market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers

Viome

LNC Therapeutics

Novome Biotechnologies

Carbiotix

Caelus Health

Ixcela, Inc

Assembly Biosciences

ProDigest

Kintai Therapeutics

AnimalBiome

Enterome BioScience

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Disease, covers:

Obesity

Inflammatory Bowel Disease (IBD)

Diabetes

Others

Market segment by Application, can be divided into

Human

Animal

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Gut Microbiome

1.2 Classification of Gut Microbiome by Disease

1.2.1 Overview: Global Gut Microbiome Revenue by Disease: 2015 Versus 2019 Versus 2025

1.2.2 Global Gut Microbiome Revenue Market Share by Disease in 2019

1.2.3 Obesity

1.2.4 Inflammatory Bowel Disease (IBD)

1.2.5 Diabetes

1.2.6 Others

1.3 Global Gut Microbiome Market by Application

1.3.1 Overview: Global Gut Microbiome Revenue by Application: 2015 Versus 2019 Versus 2025

1.3.2 Human

1.3.3 Animal

1.4 Global Gut Microbiome Market Size and Forecast (2015-2025)

1.5 Global Gut Microbiome Market Size by Regions: 2015 VS 2019 VS 2025

1.6 Global Gut Microbiome Market Size by Regions (2015-2020)

1.7 Global Gut Microbiome Market Size and Forecast by Regions (2020-2025)

1.7.1 North America Gut Microbiome Status and Prospect (2015-2025)

1.7.2 Europe Gut Microbiome Status and Prospect (2015-2025)

1.7.3 Asia Gut Microbiome Status and Prospect (2015-2025)

1.7.4 South America Gut Microbiome Status and Prospect (2015-2025)

1.7.5 Middle East & Africa Gut Microbiome Status and Prospect (2015-2025)

1.8 COVID-19 Outbreak: Gut Microbiome Industry Impact

1.8.1 COVID-19 Potential Implications for the Gut Microbiome

1.8.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Gut Microbiome

1.8.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April

1.8.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4

1.8.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2

1.8.2 Opportunity Analysis in Covid-19 Crisis

1.8.3 Market Risk and Restraints

1.8.4 Market Driving Force

2 Company Profiles

2.1 Viome

2.1.1 Viome Details

2.1.2 Viome Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Viome SWOT Analysis

2.1.4 Viome Product and Services

2.1.5 Viome Gut Microbiome Revenue, Gross Margin and Market Share (2018-2019)

2.2 LNC Therapeutics

2.2.1 LNC Therapeutics Details

2.2.2 LNC Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 LNC Therapeutics SWOT Analysis

2.2.4 LNC Therapeutics Product and Services

2.2.5 LNC Therapeutics Gut Microbiome Revenue, Gross Margin and Market Share (2018-2019)

2.3 Novome Biotechnologies

2.3.1 Novome Biotechnologies Details

2.3.2 Novome Biotechnologies Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Novome Biotechnologies SWOT Analysis

2.3.4 Novome Biotechnologies Product and Services

2.3.5 Novome Biotechnologies Gut Microbiome Revenue, Gross Margin and Market Share (2018-2019)

2.4 Carbiotix

2.4.1 Carbiotix Details

2.4.2 Carbiotix Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Carbiotix SWOT Analysis

2.4.4 Carbiotix Product and Services

2.4.5 Carbiotix Gut Microbiome Revenue, Gross Margin and Market Share (2018-2019)

2.5 Caelus Health

2.5.1 Caelus Health Details

2.5.2 Caelus Health Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Caelus Health SWOT Analysis

2.5.4 Caelus Health Product and Services

2.5.5 Caelus Health Gut Microbiome Revenue, Gross Margin and Market Share (2018-2019)

2.6 Ixcela, Inc

2.6.1 Ixcela, Inc Details

2.6.2 Ixcela, Inc Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Ixcela, Inc Product and Services

2.6.4 Ixcela, Inc Gut Microbiome Revenue, Gross Margin and Market Share (2018-2019)

2.7 Assembly Biosciences

2.7.1 Assembly Biosciences Details

2.7.2 Assembly Biosciences Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Assembly Biosciences Product and Services

2.7.4 Assembly Biosciences Gut Microbiome Revenue, Gross Margin and Market Share (2018-2019)

2.8 ProDigest

2.8.1 ProDigest Details

2.8.2 ProDigest Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 ProDigest Product and Services

2.8.4 ProDigest Gut Microbiome Revenue, Gross Margin and Market Share (2018-2019)

2.9 Kintai Therapeutics

2.9.1 Kintai Therapeutics Details

2.9.2 Kintai Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Kintai Therapeutics Product and Services

2.9.4 Kintai Therapeutics Gut Microbiome Revenue, Gross Margin and Market Share (2018-2019)

2.10 AnimalBiome

2.10.1 AnimalBiome Details

2.10.2 AnimalBiome Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 AnimalBiome Product and Services

2.10.4 AnimalBiome Gut Microbiome Revenue, Gross Margin and Market Share (2018-2019)

2.11 Enterome BioScience

2.11.1 Enterome BioScience Details

2.11.2 Enterome BioScience Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Enterome BioScience Product and Services

2.11.4 Enterome BioScience Gut Microbiome Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Gut Microbiome Market Size by Players (2015-2020)

3.2 Japan Gut Microbiome Market Size by Players (2015-2020)

3.3 Market Concentration Rate

3.3.1 Top 5 Gut Microbiome Players Market Share

3.3.2 Top 10 Gut Microbiome Players Market Share

4 North America Market Size and Forecast by Countries

4.1 North America Gut Microbiome Market Size by Countries (2015-2020)

4.2 North America Gut Microbiome Market Size and Forecast by Countries (2015-2026)

4.3 United States Gut Microbiome Market Size and Forecast (2015-2025)

4.4 Canada Gut Microbiome Market Size and Forecast (2015-2025)

4.5 Mexico Gut Microbiome Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

5.1 Europe Gut Microbiome Market Size by Countries (2015-2020)

5.2 Europe Gut Microbiome Market Size and Forecast by Countries (2015-2026)

5.3 Germany Gut Microbiome Market Size and Forecast (2015-2025)

5.4 France Gut Microbiome Market Size and Forecast (2015-2025)

5.5 UK Gut Microbiome Market Size and Forecast (2015-2025)

5.6 Russia Gut Microbiome Market Size and Forecast (2015-2025)

5.7 Italy Gut Microbiome Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

6.1 Asia-Pacific Gut Microbiome Market Size by Regions (2015-2020)

6.2 Asia-Pacific Gut Microbiome Market Size and Forecast by Regions (2015-2026)

6.3 China Gut Microbiome Market Size and Forecast (2015-2025)

6.4 Japan Gut Microbiome Market Size and Forecast (2015-2025)

6.5 Korea Gut Microbiome Market Size and Forecast (2015-2025)

6.6 India Gut Microbiome Market Size and Forecast (2015-2025)

6.7 Southeast Asia Gut Microbiome Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

7.1 South America Gut Microbiome Market Size by Countries (2015-2020)

7.2 South America Gut Microbiome Market Size and Forecast by Countries (2015-2026)

7.3 Brazil Gut Microbiome Market Size and Forecast (2015-2025)

7.4 Argentina Gut Microbiome Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

8.1 Middle East & Africa Gut Microbiome Revenue by Regions (2015-2020)

8.2 Middle East & Africa Gut Microbiome Market Size and Forecast by Countries (2015-2026)

8.3 Saudi Arabia Gut Microbiome Market Size and Forecast (2015-2025)

8.4 UAE Gut Microbiome Market Size and Forecast (2015-2025)

8.5 Egypt Gut Microbiome Market Size and Forecast (2015-2025)

8.6 South Africa Gut Microbiome Market Size and Forecast (2015-2025)

9 Market Size Segment by Disease

9.1 Global Gut Microbiome Market Size and Forecast by Disease (2015-2025)

9.1.1 Global Gut Microbiome Market Size by Disease (2015-2020)

9.1.2 Global Gut Microbiome Market Size Forecast by Disease (2020-2025)

9.2 Japan Gut Microbiome Market Size and Forecast by Disease (2015-2025)

9.2.1 Japan Gut Microbiome Market Size by Disease (2015-2020)

9.2.2 Japan Gut Microbiome Market Size Forecast by Disease (2020-2025)

10 Market Size Segment by Application

10.1 Global Gut Microbiome Market Size and Forecast by Application (2015-2025)

10.1.1 Global Gut Microbiome Market Size by Application (2015-2020)

10.1.2 Global Gut Microbiome Market Size Forecast by Application (2020-2025)

10.2 Japan Gut Microbiome Market Size and Forecast by Application (2015-2025)

10.2.1 Japan Gut Microbiome Market Size by Application (2015-2020)

10.2.2 Japan Gut Microbiome Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Data Source

12.3 Disclaimer

12.4 About US

List of Tables

Table 1. Global Gut Microbiome Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025

Table 2. Breakdown of Gut Microbiome by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Gut Microbiome Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025

Table 4. Global Market Gut Microbiome Market Size (USD Million) Comparison by Regions (2020-2025)

Table 5. Global Gut Microbiome Revenue (USD Million) by Regions (2015-2020)

Table 6. Global Gut Microbiome Revenue Share by Regions (2015-2020)

Table 7. Global Gut Microbiome Revenue (USD Million) by Regions (2020-2025)

Table 8. Global Gut Microbiome Revenue Market Share by Regions (2020-2025)

Table 9. Global Gut Microbiome Market Size and Growth Estimation in Various Scenarios in 2020

Table 10. Viome Corporate Information, Location and Competitors

Table 11. Viome Major Business

Table 12. Viome Gut Microbiome Total Revenue (USD Million) (2017-2018)

Table 13. Viome SWOT Analysis

Table 14. Viome Gut Microbiome Product and Solutions

Table 15. Viome Gut Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 16. LNC Therapeutics Corporate Information, Location and Competitors

Table 17. LNC Therapeutics Major Business

Table 18. LNC Therapeutics Gut Microbiome Total Revenue (USD Million) (2018-2019)

Table 19. LNC Therapeutics SWOT Analysis

Table 20. LNC Therapeutics Gut Microbiome Product and Solutions

Table 21. LNC Therapeutics Gut Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 22. Novome Biotechnologies Corporate Information, Location and Competitors

Table 23. Novome Biotechnologies Major Business

Table 24. Novome Biotechnologies Gut Microbiome Total Revenue (USD Million) (2017-2018)

Table 25. Novome Biotechnologies SWOT Analysis

Table 26. Novome Biotechnologies Gut Microbiome Product and Solutions

Table 27. Novome Biotechnologies Gut Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 28. Carbiotix Corporate Information, Location and Competitors

Table 29. Carbiotix Major Business

Table 30. Carbiotix Gut Microbiome Total Revenue (USD Million) (2017-2018)

Table 31. Carbiotix SWOT Analysis

Table 32. Carbiotix Gut Microbiome Product and Solutions

Table 33. Carbiotix Gut Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 34. Caelus Health Corporate Information, Location and Competitors

Table 35. Caelus Health Major Business

Table 36. Caelus Health Gut Microbiome Total Revenue (USD Million) (2017-2018)

Table 37. Caelus Health SWOT Analysis

Table 38. Caelus Health Gut Microbiome Product and Solutions

Table 39. Caelus Health Gut Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 40. Ixcela, Inc Corporate Information, Location and Competitors

Table 41. Ixcela, Inc Major Business

Table 42. Ixcela, Inc Gut Microbiome Total Revenue (USD Million) (2017-2018)

Table 43. Ixcela, Inc SWOT Analysis

Table 44. Ixcela, Inc Gut Microbiome Product and Solutions

Table 45. Ixcela, Inc Gut Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 46. Assembly Biosciences Corporate Information, Location and Competitors

Table 47. Assembly Biosciences Major Business

Table 48. Assembly Biosciences Gut Microbiome Total Revenue (USD Million) (2017-2018)

Table 49. Assembly Biosciences SWOT Analysis

Table 50. Assembly Biosciences Gut Microbiome Product and Solutions

Table 51. Assembly Biosciences Gut Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 52. ProDigest Corporate Information, Location and Competitors

Table 53. ProDigest Major Business

Table 54. ProDigest Gut Microbiome Total Revenue (USD Million) (2017-2018)

Table 55. ProDigest SWOT Analysis

Table 56. ProDigest Gut Microbiome Product and Solutions

Table 57. ProDigest Gut Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 58. Kintai Therapeutics Corporate Information, Location and Competitors

Table 59. Kintai Therapeutics Major Business

Table 60. Kintai Therapeutics Gut Microbiome Total Revenue (USD Million) (2017-2018)

Table 61. Kintai Therapeutics SWOT Analysis

Table 62. Kintai Therapeutics Gut Microbiome Product and Solutions

Table 63. Kintai Therapeutics Gut Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 64. AnimalBiome Corporate Information, Location and Competitors

Table 65. AnimalBiome Major Business

Table 66. AnimalBiome Gut Microbiome Total Revenue (USD Million) (2017-2018)

Table 67. AnimalBiome SWOT Analysis

Table 68. AnimalBiome Gut Microbiome Product and Solutions

Table 69. AnimalBiome Gut Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 70. Enterome BioScience Corporate Information, Location and Competitors

Table 71. Enterome BioScience Major Business

Table 72. Enterome BioScience Gut Microbiome Total Revenue (USD Million) (2017-2018)

Table 73. Enterome BioScience SWOT Analysis

Table 74. Enterome BioScience Gut Microbiome Product and Solutions

Table 75. Enterome BioScience Gut Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 76. Global Gut Microbiome Revenue (USD Million) by Players (2015-2020)

Table 77. Global Gut Microbiome Revenue Share by Players (2015-2020)

Table 78. Key Players Gut Microbiome Revenue (USD Million) in Japan (2015-2020)

Table 79. Key Players Gut Microbiome Revenue Share in Japan (2015-2020)

Table 80. North America Gut Microbiome Revenue (USD Million) by Countries (2015-2020)

Table 81. North America Gut Microbiome Revenue Market Share by Countries (2015-2020)

Table 82. North America Gut Microbiome Revenue (USD Million) by Countries (2020-2026)

Table 83. North America Gut Microbiome Revenue Market Share by Countries (2020-2026)

Table 84. Europe Gut Microbiome Revenue (USD Million) by Countries (2015-2020)

Table 85. Europe Gut Microbiome Revenue Market Share by Countries (2015-2020)

Table 86. Europe Gut Microbiome Revenue (USD Million) by Countries (2020-2026)

Table 87. Europe Gut Microbiome Revenue Market Share by Countries (2020-2026)

Table 88. Asia-Pacific Gut Microbiome Revenue (USD Million) by Countries (2015-2020)

Table 89. Asia-Pacific Gut Microbiome Revenue Market Share by Countries (2015-2020)

Table 90. Asia-Pacific Gut Microbiome Revenue (USD Million) by Countries (2020-2026)

Table 91. Asia-Pacific Gut Microbiome Revenue Market Share by Countries (2020-2026)

Table 92. South America Gut Microbiome Revenue (USD Million) by Countries (2015-2020)

Table 93. South America Gut Microbiome Revenue Market Share by Countries (2015-2020)

Table 94. South America Gut Microbiome Revenue (USD Million) by Countries (2020-2026)

Table 95. South America Gut Microbiome Revenue Market Share by Countries (2020-2026)

Table 96. Middle East & Africa Gut Microbiome Revenue (USD Million) by Countries (2015-2020)

Table 97. Middle East & Africa Gut Microbiome Revenue Market Share by Countries (2015-2020)

Table 98. Middle East & Africa Gut Microbiome Revenue (USD Million) by Countries (2020-2026)

Table 99. Middle East & Africa Gut Microbiome Revenue Market Share by Countries (2020-2026)

Table 100. Global Gut Microbiome Revenue (USD Million) by Disease (2015-2020)

Table 101. Global Gut Microbiome Revenue Share by Disease (2015-2020)

Table 102. Global Gut Microbiome Revenue Forecast by Disease (2020-2025)

Table 103. Global Gut Microbiome Market Share Forecast by Disease (2020-2025)

Table 104. Japan Gut Microbiome Revenue (USD Million) by Disease (2015-2020)

Table 105. Japan Gut Microbiome Revenue Share by Disease (2015-2020)

Table 106. Japan Gut Microbiome Revenue Forecast by Disease (2020-2025)

Table 107. Japan Gut Microbiome Market Share Forecast by Disease (2020-2025)

Table 108. Global Gut Microbiome Revenue (USD Million) by Application (2015-2020)

Table 109. Global Gut Microbiome Revenue Share by Application (2015-2020)

Table 110. Global Gut Microbiome Revenue Forecast by Application (2020-2025)

Table 111. Global Gut Microbiome Market Share Forecast by Application (2020-2025)

Table 112. Japan Gut Microbiome Revenue (USD Million) by Application (2015-2020)

Table 113. Japan Gut Microbiome Revenue Share by Application (2015-2020)

Table 114. Japan Gut Microbiome Revenue Forecast by Application (2020-2025)

Table 115. Japan Gut Microbiome Market Share Forecast by Application (2020-2025)

Table 116.List of Figures

Table 117. Gut Microbiome Picture

Table 118. Global Gut Microbiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Table 119. Global Gut Microbiome Revenue Market Share by Disease in 2019

Table 120. Obesity Picture

Table 121. Inflammatory Bowel Disease (IBD) Picture

Table 122. Diabetes Picture

Table 123. Others Picture

Table 124. Gut Microbiome Revenue Market Share by Application in 2019

Table 125. Human Picture

Table 126. Animal Picture

Table 127. Global Gut Microbiome Revenue and Growth Rate (2015-2025) (USD Million)

Table 128. Global Gut Microbiome Market Size Share by Regions (2015-2025)

Table 129. Global Gut Microbiome Market Size Share by Regions in 2019

Table 130. Global Gut Microbiome Revenue Market Share by Regions (2020-2025)

Table 131. North America Gut Microbiome Revenue (USD Million) and Growth Rate (2015-2025)

Table 132. Europe Gut Microbiome Revenue (USD Million) and Growth Rate (2015-2025)

Table 133. Asia-Pacific Gut Microbiome Revenue (USD Million) and Growth Rate (2015-2025)

Table 134. South America Gut Microbiome Revenue (USD Million) and Growth Rate (2015-2025)

Table 135. Middle East & Africa Gut Microbiome Revenue (USD Million) and Growth Rate (2015-2025)

Table 136. Global Gut Microbiome Revenue Share by Players in 2019

Table 137. Global Top 5 Players Gut Microbiome Revenue Market Share in 2019

Table 138. Top 10 Players Gut Microbiome Revenue Market Share in Global Market in 2019

Table 139. Global Gut Microbiome Market Size (USD Million) by Disease (2015-2025)

Table 140. Global Gut Microbiome Market Size Share by Application (2015-2025)

Table 141. North America Gut Microbiome Market Size Share by Countries (2015-2025)

Table 142. North America Gut Microbiome Market Size Share by Countries in 2019

Table 143. United States Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 144. Canada Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 145. Mexico Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 146. Europe Gut Microbiome Market Size Share by Countries (2015-2025)

Table 147. Europe Gut Microbiome Market Size Share by Countries in 2019

Table 148. Germany Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 149. France Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 150. Russia Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 151. Italy Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 152. Spain Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 153. UK Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 154. Asia Gut Microbiome Market Size Share by Countries (2015-2025)

Table 155. Asia Gut Microbiome Market Size Share by Countries in 2019

Table 156. China Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 157. Japan Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 158. Korea Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 159. India Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 160. Southeast Asia Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 161. South America Gut Microbiome Market Size Share by Countries (2015-2025)

Table 162. South America Gut Microbiome Market Size Share by Countries in 2019

Table 163. Brazil Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 164. Argentina Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 165. Middle East & Africa Gut Microbiome Market Size Share by Countries (2015-2025)

Table 166. Middle East & Africa Gut Microbiome Market Size Share by Countries in 2019

Table 167. Saudi Arabia Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 168. UAE Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 169. Egypt Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 170. South Africa Gut Microbiome Market Size (USD Million) and Forecast (2015-2025)

Table 171. Global Gut Microbiome Revenue Share by Disease (2015-2020)

Table 172. Japan Gut Microbiome Revenue Share by Disease (2015-2020)

Table 173. Global Gut Microbiome Revenue Share by Application (2015-2020)

Table 174. Japan Gut Microbiome Revenue Share by Application (2015-2020)